Clinical Trials Browser

Phase 2 × OTHER × gp100 Melanoma Antigen × Clear all

NCT00960752 2021-08-13

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Phase 2 Completed

47 enrolled 9 charts

Melanoma, Neoplasm Metastasis, Neoplasms

NCT00085189 2014-05-22

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

Phase 2 Completed

Uveal Melanoma, Melanoma